Characterization of the Microbiome in Cutaneous T Cell Lymphoma

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT03932279
Status
Recruiting
Apply to this trial

Conditions

  • Cutaneous T Cell Lymphoma

Eligibility Criteria

Sex
ALL
Age
18 Years - 89 Years
Healthy Volunteers
Accepted

Study Details

Investigators plan to perform a pilot study that aims to characterize the microbiome of human cutaneous T cell lymphoma patients and compare this to the microbiome of age and sex matched controls.

Key Dates

Start date
Jan 30, 2019
Status verified
Apr 2025
Primary completion
Feb 28, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Stage IA-IIA cutaneous T cell lymphoma
  • Arm: Stage IIB and above cutaneous T cell lymphoma
  • Arm: CD30+ lymphoproliferative disorders
  • Arm: Plaque psoriasis with BSA>5% on routine phototherapy
  • Arm: Moderate to severe atopic dermatitis on routine bleach bath
  • Arm: Healthy controls

Primary Outcome Measure

Bacterial diversity index [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Northwestern UniversityChicagoIllinois60611
Dermatology CTU
[email protected]
312-503-5944
Alan Zhou, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By research site
Northwestern University· Chicago, IL

Related Studies